Analyst consensus ratings for TerrAscend typically fluctuate between a speculative buy and a cautious hold, depending on individual equity research firms and evolving market conditions. Proponents emphasize its strong market positioning in limited-license states like New Jersey, robust revenue growth, and improving EBITDA margins. Conversely, more conservative analysts point to regulatory uncertainties, federal scheduling hurdles, and capital-intensive market expansions as reasons to maintain a neutral stance or wait for clearer paths to absolute net profitability.